First experimental vaccine for coronavirus ready for human testing

dc ca afde eb f e c cf

Moderna has become the first company to release a potential coronavirus vaccine, with the Boston-based biotech start-up announcing on Monday [February 24] that it had sent the vials to the US National Institutes of Health to be tested in humans.

Juan Andres, chief technical operations and quality officer at Moderna, said it was an “extraordinary effort” responding to the global health emergency with a “record speed” of 42 days from when the virus’ genome was sequenced.


The vaccine still needs to be tested in humans, where it could fail, and if it succeeds, it will still take months until it is widely available. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, part of the NIH, told the Wall Street Journal that he expects a clinical trial of about 20 to 25 healthy volunteers to start in April, with initial results available in July and August.

Related article:  Is climate change dampening our ability to fight the coronavirus and other diseases?

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend